Market Overview

Benzinga's Top Pre-Market Gainers

Share:
Related OREX
Stocks Hitting 52-Week Lows
Orexigen Up, Then Steeply Down Following Contrave U.S. Rights Agreement
The End Of Another Chapter In Obesity Drug Development (Seeking Alpha)
Related AVNR
Avanir Pharmaceuticals to Present Data on ONZETRA™ Xsail™ at American Headache Society (AHS) 2016 Annual Scientific Meeting
Top 4 NASDAQ Stocks In The Drugs Generic Industry With The Highest EPS Growth Forecast For Next 5 Years

Orexigen Therapeutics (NASDAQ: OREX) moved up 4.56% to $7.57 in the pre-market session. Orexigen shares have jumped 64.17% over the past 52 weeks, while the S&P 500 index has gained 17.56% in the same period.

Tiffany & Co (NYSE: TIF) surged 2.24% to $83.50 in the pre-market session after the company reported a rise in its Q2 profit.

MannKind (NASDAQ: MNKD) soared 2.08% to $5.90 in the pre-market trading. MannKind's PEG ratio is 0.06.

Newmont Mining (NYSE: NEM) shares gained 1.89% to $33.92 in the pre-market session. Newmont Mining has a dividend yield of 3%.

Posted-In: Top Pre-Market GainersNews Pre-Market Outlook Markets Movers

 

Related Articles (MNKD + NEM)

View Comments and Join the Discussion!